Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.
about
CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin.Genetic variation in the UGT1A locus is associated with simvastatin efficacy in a clinical practice setting.Effect of polymorphisms in CYP3A4, PPARA, NR1I2, NFKB1, ABCG2 and SLCO1B1 on the pharmacokinetics of lovastatin in healthy Chinese volunteers.
P2860
Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.
@en
Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.
@nl
type
label
Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.
@en
Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.
@nl
prefLabel
Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.
@en
Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.
@nl
P2093
P2860
P1476
Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.
@en
P2093
Anna Tavridou
Constantinos Mihas
Genovefa Kolovou
Georgia Ragia
Ioannis Vasiliadis
Niki Katsiki
Sophie Mavrogeni
Vana Kolovou
Vangelis G Manolopoulos
Vassiliki Vartela
P2860
P356
10.2174/1874192401408010012
P577
2014-02-07T00:00:00Z